These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 4317556)

  • 41. Serogroup B meningococcal disease--Oregon, 1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1995 Feb; 44(7):121-4. PubMed ID: 7845348
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Meningococcal infections in England and Wales: 1993.
    Jones DM; Kaczmarski EB
    Commun Dis Rep CDR Rev; 1994 Aug; 4(9):R97-100. PubMed ID: 7522809
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Trends in disease caused by Neisseria meningitidis: 1972 and 1973.
    McCormick JB; Weaver RE; Thornsberry C; Feldman RA
    J Infect Dis; 1974 Aug; 130(2):212-4. PubMed ID: 4210454
    [No Abstract]   [Full Text] [Related]  

  • 44. Neisseria meningitidis with reduced sensitivity to penicillin: observations in 10 children.
    Uriz S; Pineda V; Grau M; Nava JM; Bella F; Morera MA; Fontanals D; Font B; Martí C; Deulofeu F
    Scand J Infect Dis; 1991; 23(2):171-4. PubMed ID: 1906633
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Active surveillance of meningococcal meningitis in Poland.
    Tyski S; Grzybowska W; Lind I
    Cent Eur J Public Health; 1998 Aug; 6(3):219-24. PubMed ID: 9787924
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasmid carriage and antibiotic susceptibility of Neisseria meningitidis strains isolated in Sweden 1981-1990.
    Bäckmann A; Danielsson D; Olcén P
    Eur J Clin Microbiol Infect Dis; 1993 Sep; 12(9):683-9. PubMed ID: 8243484
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antimicrobial resistance of Neisseria meningitidis in the United States, 1997. The Active Bacterial Core Surveillance (ABCs) Team.
    Rosenstein NE; Stocker SA; Popovic T; Tenover FC; Perkins BA
    Clin Infect Dis; 2000 Jan; 30(1):212-3. PubMed ID: 10619761
    [No Abstract]   [Full Text] [Related]  

  • 48. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2004, through 31 December, 2005.
    Can Commun Dis Rep; 2007 Jun; 33(10):1-15. PubMed ID: 17691125
    [No Abstract]   [Full Text] [Related]  

  • 49. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2002, through 31 December, 2003.
    Can Commun Dis Rep; 2006 Apr; 32(8):97-107. PubMed ID: 16685767
    [No Abstract]   [Full Text] [Related]  

  • 50. The meningococcal carrier-rate.
    Fraser PK; Bailey GK; Abbott JD; Gill JB; Walker DJ
    Lancet; 1973 Jun; 1(7814):1235-7. PubMed ID: 4122576
    [No Abstract]   [Full Text] [Related]  

  • 51. Neisseria meningitidis in the 1990s.
    King WJ; MacDonald NE
    Adv Pediatr Infect Dis; 1997; 13():143-64. PubMed ID: 9544311
    [No Abstract]   [Full Text] [Related]  

  • 52. Antagonism limit of penicillin G and chloramphenicol against Neisseria meningitidis.
    Yourassowsky E; Monsieur R
    Arzneimittelforschung; 1971 Sep; 21(9):1385-7. PubMed ID: 5003020
    [No Abstract]   [Full Text] [Related]  

  • 53. [On the present in vitro-susceptibility of N. meningitidis to benzyl-penicillin. A survey based on 82 fresh isolates from bacterial carriers belonging to the German Army (author's transl)].
    Korting HC; Haag R
    Zentralbl Bakteriol A; 1980; 248(1):129-33. PubMed ID: 6781165
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Microheterogeneity of serogroup A (subgroup III) Neisseria meningitidis during an outbreak in northern Ghana.
    Gagneux S; Hodgson A; Ehrhard I; Morelli G; Genton B; Smith T; Tanner M; Binka F; Achtman M; Pluschke G
    Trop Med Int Health; 2000 Apr; 5(4):280-7. PubMed ID: 10810025
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence of Neisseria meningitidis serogroups in Egypt.
    Sippel JE; Girgis NI; el-Ghoroury A; Wahdan MH; Hablas R; Rahka AE
    Trop Geogr Med; 1973 Dec; 25(4):350-4. PubMed ID: 4206822
    [No Abstract]   [Full Text] [Related]  

  • 56. Meningococcal infections in Scotland.
    Fallon RJ
    J Med Microbiol; 1988 Jul; 26(3):168-72. PubMed ID: 3134547
    [No Abstract]   [Full Text] [Related]  

  • 57. Epidemiology of meningococcal disease in southern Brazil from 1995 to 2003, and molecular characterization of Neisseria meningitidis using multilocus sequence typing.
    Baethgen LF; Weidlich L; Moraes C; Klein C; Nunes LS; Cafrune PI; Lemos AP; Rios SS; Abreu MF; Kmetzsch C; Sperb AF; Riley LW; Rossetti ML; Zaha A
    Trop Med Int Health; 2008 Jan; 13(1):31-40. PubMed ID: 18290999
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [In vitro bactericidal activity of seven antibiotics and four combinations against Neisseria meningitidis].
    Nizou JY; Cavallo JD; Crenn Y; Bartoli M; Meyran M
    Pathol Biol (Paris); 1994 May; 42(5):393-8. PubMed ID: 7824302
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Enzymatic make-up of strains of Neisseria meningitidis sensitive and resistant to streptomycin. Study of oxidative metabolism].
    Szabados J; Topciu A; Dimache V
    Arch Roum Pathol Exp Microbiol; 1967 Mar; 26(1):195-204. PubMed ID: 4386356
    [No Abstract]   [Full Text] [Related]  

  • 60. [In vitro sensitivity of meningococci and the implications for prevention].
    Yourassowsky E; Schoutens E; Vanderlinden MP
    Arch Belg Med Soc; 1973; 31(6):449-54. PubMed ID: 4205263
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.